1629.9000 3.00 (0.18%)
NSE Sep 25, 2025 14:20 PM
Volume: 51,109
 

1629.90
0.18%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.
More from Eris Lifesciences Ltd.
Recommended